Home » ViroPharma Receives Complete Response Letter for Cinryze
ViroPharma Receives Complete Response Letter for Cinryze
ViroPharma Incorporated announced the U.S. Food and Drug Administration issued a complete response letter regarding Cinryze (C1 Esterase Inhibitor [Human]) industrial scale manufacturing expansion activities.
heraldonline
heraldonline
Upcoming Events
-
07May
-
14May
-
30May